Vivos Therapeutics Inc
vivos.comWhat Do They Do?
Sells oral appliances and provides sleep tests and treatment for people with sleep apnea through dentists and sleep centers.
10-K for FY2025, filed Apr 15, 2026We are a revenue stage medical technology and healthcare services company that features a comprehensive suite of proprietary oral…View ↗
Because of the close connection and relationship between the oral cavity and airway form and function, properly trained dentists, sleep…View ↗
As we have established a national network of Vivos-trained dentists, we are pivoting our focus to the source of where we believe the vast…View ↗
How Do They Make Money?
Dentists and patients buy oral appliances and tooth positioners; product sales are tied to shipment. The company also earns fees from sleep testing, patient treatment, training and billing services, with some service fees spread across the period those services are provided.
10-K for FY2025, filed Apr 15, 2026In addition to revenue from services, we also generate revenue from sales of our line of oral devices and preformed pediatric tooth…View ↗
Under our legacy VIP model, revenue from appliance sales is recognized when the control of a product is transferred to the VIP in an amount…View ↗
Under our new sales, marketing and distribution strategy, we train and provide other administrative and non-clinical management support…View ↗
(1) Product revenue from the sale of appliances and tooth positioners is typically fixed at the inception of the contract and is recognized…View ↗
BIS is an additional service provided on a monthly subscription basis, which includes our AireO2 medical billing and practice management…View ↗
-
10-K for FY2025, filed Apr 15, 2026
FY2025 revenue by product or service ↗
$17.4M
-
10-K for FY2025, filed Apr 15, 2026
$17.4M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2025, filed Apr 15, 2026 |
37%
FY2022: 52%
|
Product, FY2025
$6.5M Sources
|
Sold outright |
|
Service
Mix
10-K for FY2025, filed Apr 15, 2026 |
63%
FY2022: 48%
|
Service, FY2025
$11M Sources
|
Mix |
Who Are Their Customers?
Dentists buy appliances for use with patients; the newer model offers testing and treatment directly to patients through company centers and collaborating medical providers.
10-K for FY2025, filed Apr 15, 2026In addition to revenue from services, we also generate revenue from sales of our line of oral devices and preformed pediatric tooth…View ↗
Under our legacy VIP model, revenue from appliance sales is recognized when the control of a product is transferred to the VIP in an amount…View ↗
Under our new sales, marketing and distribution strategy, we train and provide other administrative and non-clinical management support…View ↗
As we shift to our new strategic acquisition and alliance business model, we derive a greater portion of our revenues from treatment of…View ↗
Do Revenues Turn Into Profits?
No. It lost $21.2M in FY2025.
10-K for FY2025, filed Apr 15, 2026
−$19.9MView ↗
10-K for FY2025, filed Apr 15, 2026
−$21.2MView ↗
10-K for FY2025, filed Apr 15, 2026
−$17.6MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 14, 2026
−$5.5MView ↗
- ▲ +10% (Loss)
- vs −$5M in Q2 FY2025
10-Q for Q2 FY2026, filed Aug 14, 2026
Open tableView ↗
-
Aug 3, 2026
Chief financial officer resigned and successor was appointed
Bradford Amman resigned, and Roman Franklin was appointed effective the same date.
Sources
8-K, filed Aug 3, 2026
On July 31, 2026, Bradford Amman resigned as Chief Financial Officer and Secretary of the Company, and from all other officer and committee…View ↗
-
Jun 16, 2026
Signed collaboration agreement to form a Florida medical-services organization
The planned organization would support sleep apnea testing and treatment through a cardiovascular practice.
Sources
8-K, filed Jun 16, 2026
On June 10, 2026, Vivos Therapeutics, Inc. (the “Company”) entered into a Collaboration Agreement (the “Collaboration Agreement”) with…View ↗
Flat. Revenue was $17.4M in FY2025, about the same as the $16.9M of FY2021.
From dentists to medical-provider relationships
The older report centers on dentists and their subscription-based training program. The latest describes alliances with and acquisitions of sleep practices, plus administrative support and treatment delivered to patients through those providers.
10-K for FY2022, filed Mar 30, 2023 10-K for FY2025, filed Apr 15, 2026Over the course of 2024 and 2025, we worked to pivot our business strategy and began to steadily decrease our prior dependence on enrolling…View ↗
In June 2025, our new business model was set in motion when we acquired all assets, including operating assets such as sleep testing…View ↗
Under our new sales, marketing and distribution strategy, we train and provide other administrative and non-clinical management support…View ↗
Loading...
